Addressing Prescription Drug Abuse Requires Focus


Improving the prescribing and use of pain relievers – all prescription drugs, in fact – is a necessity. It should rest in the hands of those with authority and experience on the matter: medical and pharmacy boards, professional societies, and patient advocacy organizations, among others. The FDA, in focusing its efforts on these matters, is being distracted from its core responsibilities: expediting the development of innovative medicines, and evaluating them with urgency to meet public health needs. If the FDA focuses its attention on making safer medications available to prescribers, it can make a real difference in the lives of patients with dire medical needs and, indeed, all of us affected by prescription drug abuse.

LOADING PDF: If there are any problems, click here to download the file.

Published In: Administrative Agency Updates, Health Updates

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Michael Barnes, DCBA Law & Policy | Attorney Advertising

Don't miss a thing! Build a custom news brief:

Read fresh new writing on compliance, cybersecurity, Dodd-Frank, whistleblowers, social media, hiring & firing, patent reform, the NLRB, Obamacare, the SEC…

…or whatever matters the most to you. Follow authors, firms, and topics on JD Supra.

Create your news brief now - it's free and easy »